检索结果 - Martha Arellano

Refine Results
  1. 1
    Current advances in identification of cancer biomarkers in saliva

    Current advances in identification of cancer biomarkers in saliva 由 Martha Arellano

    出版 2009
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience

    Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience 由 Martha Arellano, Amelia Langston, Elliott F. Winton, Christopher R. Flowers, Edmund K. Waller

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Identification of Tetranectin as a Potential Biomarker for Metastatic Oral Cancer

    Identification of Tetranectin as a Potential Biomarker for Metastatic Oral Cancer 由 Martha Arellano-Garcia, Roger Li, Xiaojun Liu, Yongming Xie, Xiaofei Yan, Joseph A. Loo, Shen Hu

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays

    Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays 由 Shen Hu, Arjan Vissink, Martha Arellano, Caroline Roozendaal, Hui Zhou, Cees G. M. Kallenberg, David T. Wong

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Salivary Proteomics for Oral Cancer Biomarker Discovery

    Salivary Proteomics for Oral Cancer Biomarker Discovery 由 Shen Hu, Martha Arellano, Pinmanee Boontheung, Jianghua Wang, Hui Zhou, Jiang Jiang, David Elashoff, Roger Wei, Joseph A. Loo, David T. Wong

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Preclinical validation of salivary biomarkers for primary Sjögren's syndrome

    Preclinical validation of salivary biomarkers for primary Sjögren's syndrome 由 Shen Hu, Kai Gao, Rodney Pollard, Martha Arellano-Garcia, Hui Zhou, Lei Zhang, David Elashoff, Cees G. M. Kallenberg, Arjan Vissink, David T. Wong

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Electrochemical Sensor for Multiplex Biomarkers Detection

    Electrochemical Sensor for Multiplex Biomarkers Detection 由 Wei Fang, Prabhudas S. Patel, Wei Liao, Kishore Chaudhry, Lei Zhang, Martha Arellano-Garcia, Shen Hu, David Elashoff, Hui Zhou, Shilin N. Shukla, Franky D. Shah, Chih‐Ming Ho, David T. Wong

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin

    Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin 由 Shannon Elf, Richard Z. Lin, Siyuan Xia, Yaozhu Pan, Changliang Shan, Shengjie Wu, Sagar Lonial, Manila Gaddh, Martha Arellano, H. Jean Khoury, Fadlo R. Khuri, Brendan Lee, Titus J. Boggon, Jun Fan, J Chen

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease

    Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease 由 H. Jean Khoury, Amelia Langston, Vamsi Kota, Jennifer A. Wilkinson, Iskra Pusic, Anand Jillella, Stephanie Bauer, Audrey S Kim, Danielle Roberts, Zaid Al‐Kadhimi, Imre Bodó, Elliott F. Winton, Martha Arellano, John F. DiPersio

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Safety and Efficacy of Menin Inhibition in Patients (Pts) with MLL-Rearranged and NPM1 Mutant Acute Leukemia: A Phase (Ph) 1, First-in-Human Study of SNDX-5613 (AUGMENT 101)

    Safety and Efficacy of Menin Inhibition in Patients (Pts) with MLL-Rearranged and NPM1 Mutant Acute Leukemia: A Phase (Ph) 1, First-in-Human Study of SNDX-5613 (AUGMENT 101) 由 Eytan M. Stein, Ibrahim Aldoss, John F. DiPersio, Richard M. Stone, Martha Arellano, Galit Rosen, Michael L. Meyers, Yifan Huang, Steve Smith, Rebecca G. Bagley, Michael J. Thirman, Manish R. Patel, Ghayas C. Issa

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    A phase 1 dose‐escalation study of ARRY‐520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias

    A phase 1 dose‐escalation study of ARRY‐520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias 由 H. Jean Khoury, Guillermo Garcia‐Manero, Gautam Borthakur, Tapan Kadia, Maria Cielo Foudray, Martha Arellano, Amelia Langston, Beverly Bethelmie‐Bryan, Selena Rush, Kevin Litwiler, Sharon Karan, Heidi Simmons, Adam I. Marcus, Mieke Ptaszynski, Hagop M. Kantarjian

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Tyr-94 Phosphorylation Inhibits Pyruvate Dehydrogenase Phosphatase 1 and Promotes Tumor Growth

    Tyr-94 Phosphorylation Inhibits Pyruvate Dehydrogenase Phosphatase 1 and Promotes Tumor Growth 由 Changliang Shan, Hee‐Bum Kang, Shannon Elf, Jianxin Xie, Ting-Lei Gu, Mike Aguiar, Scott Lonning, Taro Hitosugi, Tae‐Wook Chung, Martha Arellano, H. Jean Khoury, Dong M. Shin, Fadlo R. Khuri, Titus J. Boggon, Jun Fan

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow‐up from a phase 1b study

    Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow‐up from a phase 1b study 由 Daniel A. Pollyea, Keith W. Pratz, Anthony Letai, Brian A. Jonas, Andrew H. Wei, Vinod Pullarkat, Marina Konopleva, Michael J. Thirman, Martha Arellano, Pamela S. Becker, Brenda Chyla, Wan‐Jen Hong, Qi Jiang, Jalaja Potluri, Courtney D. DiNardo

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults With Acute Myeloid Leukemia and Unfavorable Prognostic Factors

    Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults With Acute Myeloid Leukemia and Unfavorable Prognostic Factors 由 Hagop M. Kantarjian, Harry P. Erba, David F. Claxton, Martha Arellano, Roger M. Lyons, T.J. Kovascovics, Janice Gabrilove, Michael Craig, Dan Douer, Michael B. Maris, Stephen H. Petersdorf, Paul J. Shami, Andrew M. Yeager, Stephen Eckert, Rekha Abichandani, Stefan Faderl

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Tyr-301 Phosphorylation Inhibits Pyruvate Dehydrogenase by Blocking Substrate Binding and Promotes the Warburg Effect

    Tyr-301 Phosphorylation Inhibits Pyruvate Dehydrogenase by Blocking Substrate Binding and Promotes the Warburg Effect 由 Jun Fan, Hee‐Bum Kang, Changliang Shan, Shannon Elf, Ruiting Lin, Jianxin Xie, Ting‐Lei Gu, Mike Aguiar, Scott Lonning, Tae‐Wook Chung, Martha Arellano, H. Jean Khoury, Dong M. Shin, Fadlo R. Khuri, Titus J. Boggon, Sumin Kang, Jing Chen

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    International Randomized Phase III Study of Elacytarabine Versus Investigator Choice in Patients With Relapsed/Refractory Acute Myeloid Leukemia

    International Randomized Phase III Study of Elacytarabine Versus Investigator Choice in Patients With Relapsed/Refractory Acute Myeloid Leukemia 由 Gail J. Roboz, Todd Rosenblat, Martha Arellano, Marco Gobbi, Jessica K. Altman, Pau Montesinos, Casey L. O’Connell, Scott R. Solomon, Arnaud Pigneux, Norbert Vey, Robert K. Hills, Tove Flem Jacobsen, Athos Gianella-Borradori, Øivind Foss, Sylvia Vetrhusand, Francis J. Giles

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

    Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia 由 Courtney D. DiNardo, Keith W. Pratz, Vinod Pullarkat, Brian A. Jonas, Martha Arellano, Pamela S. Becker, Olga Frankfurt, Marina Konopleva, Andrew H. Wei, Hagop M. Kantarjian, Tu Xu, Wan-Jen Hong, Brenda Chyla, Jalaja Potluri, Daniel A. Pollyea, Anthony Letai

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and <i>IDH1/2</i> Mutations

    Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and <i>IDH1/2</i> Mutations 由 Daniel A. Pollyea, Courtney D. DiNardo, Martha Arellano, Arnaud Pigneux, Walter Fiedler, Marina Konopleva, David A. Rizzieri, B. Douglas Smith, Atsushi Shinagawa, Roberto M. Lemoli, Monique Dail, Yinghui Duan, Brenda Chyla, Jalaja Potluri, Catherine L. Miller, Hagop M. Kantarjian

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study

    Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study 由 Hagop M. Kantarjian, Stefan Faderl, Guillermo Garcia‐Manero, Selina M. Luger, Parameswaran Venugopal, Lori J. Maness, Meir Wetzler, Steven Coutré, Wendy Stock, David F. Claxton, Stuart L. Goldberg, Martha Arellano, Stephen A. Strickland, Karen Seiter, Gary J. Schiller, Elias Jabbour, Judy H. Chiao, William Plunkett

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results

    Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results 由 Jorge E. Cortés, Benjamin D. Smith, Eunice S. Wang, Akil Merchant, Vivian G. Oehler, Martha Arellano, Daniel J. DeAngelo, Daniel A. Pollyea, Mikkael A. Sekeres, Tadeusz Robak, Weidong Wendy, Mirjana Zeremski, M. Naveed Shaik, A. Douglas Laird, Ashleigh O’Connell, Geoffrey Chan, Mark A. Schroeder

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: